A new round of Medicare drug price negotiations shows the impact of the Inflation Reduction Act while exposing an ongoing political fight over who deserves credit for lowering drug costs. The Trump ...

Some states are rethinking their coverage of GLP-1 drugs for weight loss as budgets tighten and Medicaid programs brace for ...

Pharmacies will be the canary in the coal mine for the Medicare Drug Price Negotiation Program, writes Sujith Ramachandran.

The new prices were made possible by the Medicare negotiation program created under the Biden administration's Inflation ...

The government said Tuesday that Novo Nordisk's (NVO) drugs - Ozempic and Rybelsus for Type 2 diabetes - will cost $274 for a month's supply in 2027 for people covered by Medicare. Wegovy, which is ...

In 2026, there are fewer prescription drug plans in Medicare Part D and higher premiums, even when offset by a ...

Discover how new U.S. Medicare drug price cuts impact major pharma stocks like Novo Nordisk and why sector resilience ...

The Trump administration tapped a Biden-era rule to negotiate lower prices on 15 widely used medications for seniors.

The agency is able to negotiate some drug prices for Medicare recipients because of a bill signed by former President Joe ...

Pharmacy benefit managers (PBMs) are back in the crosshairs. PBMs negotiate drug prices down on behalf of consumers and insurers – to the ire of ...